Lene Kongsgaard Nielsen

Fingerprint Dive into the research topics where Lene Kongsgaard Nielsen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

Quality of Life Medicine & Life Sciences

Clarithromycin Medicine & Life Sciences

Longitudinal Studies Medicine & Life Sciences

Melphalan Medicine & Life Sciences

Hematology Medicine & Life Sciences

Placebos Medicine & Life Sciences

Research Medicine & Life Sciences

Patient Outcome Assessment Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2019

11 Journal article
10 Poster
10 Conference abstract in journal
8 Conference abstract for conference
4 More

A phase 2 study of carfilzomib plus elotuzumab plus dexamethasone for myeloma patients relapsed after 1-3 prior treatment lines

Silvennoinen, R., Majumder, M. M., Tsallos, D., Nahi, H., Anttila, P., Partanen, A., Nurmi, M., Luoma, S., Sikiö, A., Varmavuo, V., Säily, M., Sankelo, M., Jantunen, E., Pelliniemi, T-T., Ilveskero, S., Eshoj, H., Kongsgaard Nielsen, L., Eldfors, S., Leppä, A-M. & Heckman, C., Oct 2019, p. e279.

Research output: Contribution to conference without publisher/journal › Poster › Research › peer-review

A phase 2 study of carfilzomib plus elotuzumab plus dexamethasone for myeloma patients relapsed after 1-3 prior treatment lines

Silvennoinen, R., Majumder, M. M., Tsallos, D., Nahi, H., Anttila, P., Partanen, A., Nurmi, M., Luoma, S., Sikiö, A., Varmavuo, V., Säily, M., Sankelo, M., Jantunen, E., Pelliniemi, T-T., Ilveskero, S., Eshoj, H., Kongsgaard Nielsen, L., Eldfors, S., Leppä, A-M. & Heckman, C., Oct 2019, In : Clinical Lymphoma, Myeloma & Leukemia. 19, 10 Supplement, p. e279

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

44 Downloads (Pure)

Clarithromycin added to bortezomib‐cyclophosphamide‐dexamethasone impairs health‐related quality of life in multiple myeloma patients

Nielsen, L. K., Klausen, T. W., Jarden, M., Frederiksen, H., Vangsted, A. J., Do, T., Kristensen, I. B., Frølund, U. C., Andersen, C. L., Abildgaard, N. & Gregersen, H., Jan 2019, In : European Journal of Haematology. 102, 1, p. 70-78

Research output: Contribution to journal › Journal article › Research › peer-review

Open Access

File

Clarithromycin

Quality of Life

Placebos

Half of patients with multiple myeloma with rehabilitation needs report moderate to severe symptoms or functional problems

Kongsgaard Nielsen, L., Larsen, R. F., Jarlbæk, L., Möller, S. & Jespersen, E., 5. Sep 2019.

Research output: Contribution to conference without publisher/journal › Conference abstract for conference › Research

Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study

Nielsen, L. K., Stege, C., Lissenberg-Witte, B., van der Holt, B., Mellqvist, U-H., Salomo, M., Bos, G., Levin, M-D., Visser-Wisselaar, H., Hansson, M., van der Velden, A., Deenik, W., Coenen, J., Hinge, M., Klein, S., Tanis, B., Szatkowski, D., Brouwer, R., Westerman, M., Leys, R. & 10 others, Sinnige, H., Haukås, E., van der Hem, K., Durian, M., Gimsing, P., van de Donk, N., Sonneveld, P., Waage, A., Abildgaard, N. & Zweegman, S., 12. Sep 2019, In : Haematologica.

Research output: Contribution to journal › Journal article › Research › peer-review

Quality of Life

Melphalan

Linear Models

Maintenance

Incidence